Global Retirement Partners’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Global Retirement Partners’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.82K	Buy	+103	New	+$6.03K	﹤0.01%	3577
2025 Q4	$5.75K	Sell	103 -10	-9%	-$518	﹤0.01%	3387
2025 Q3	$5.4K	Sell	113 -10	-8%	-$447	﹤0.01%	2949
2025 Q2	$4.98K	Buy	+123	New	+$4.94K	﹤0.01%	2912
2024 Q4	$5.24K	Buy	122 +1	+0.8%	+$45	﹤0.01%	2659
2024 Q3	$5.38K	Hold	121	–	–	﹤0.01%	2532
2024 Q2	$4.81K	Sell	121 -150	-55%	-$6.08K	﹤0.01%	2631
2024 Q1	$11.7K	Buy	+271	New	+$11.7K	﹤0.01%	2058

Other funds holding XPH

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

KWM

Kingsview Wealth Management Grants Pass, Oregon $8.25B AUM 24.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Evelyn Partners London $46.9B AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Global Retirement Partners's XPH Position: Q2 2026 in Review

Global Retirement Partners opened a new position in State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q2 2026: 103 shares worth $6.82K. The stake represents ﹤0.01% of the portfolio and ranks #3577 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in XPH as recently as Q4 2025.

Global Retirement Partners first reported a position in XPH in Q1 2024 and has held it in 8 quarters since. The position peaked at $11.7K in Q1 2024. 92 funds tracked by Wall St. Rank hold XPH as of Q2 2026.

Global Retirement Partners held 103 shares of State Street SPDR S&P Pharmaceuticals ETF worth $6.82K as of Q2 2026.
State Street SPDR S&P Pharmaceuticals ETF was a new Global Retirement Partners position in Q2 2026.
State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #3577 holding.
Global Retirement Partners first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2024 and has held it in 8 quarters since.
Global Retirement Partners's State Street SPDR S&P Pharmaceuticals ETF position peaked at $11.7K in Q1 2024.
92 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.